EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Class I and II Histone Deacetylase Inhibitors as Therapeutic Modulators of Dilated Cardiac Tissue-Derived Mesenchymal Stem/Stromal Cells

Rokas Mikšiūnas, Siegfried Labeit iD, Daiva Bironaite

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25126758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Rokas Mikšiūnas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Santariškių 5, LT-08406 Vilnius, Lithuania. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Mesenchymal Stem Cells, Cardiomyopathy, Dilated, Cell Differentiation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lithuanian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of dilated cardiomyopathy (DCM) is increasing globally, highlighting the need for innovative therapeutic approaches to prevent its onset. In this study, we examined the energetic and epigenetic distinctions between dilated and non-dilated human myocardium-derived mesenchymal stem/stromal cells (hmMSCs) and assessed the effects of class I and II HDAC inhibitors (HDACi) on these cells and their cardiomyogenic differentiation. Cells were isolated from myocardium biopsies using explant outgrowth methods. Mitochondrial and histone deacetylase activities, ATP levels, cardiac transcription factors, and structural proteins were assessed using flow cytometry, PCR, chemiluminescence, Western blotting, and immunohistochemistry. The data suggest that the tested HDAC inhibitors improved acetylation and enhanced the energetic status of both types of cells, with significant effects observed in dilated myocardium-derived hmMSCs. Additionally, the HDAC inhibitors activated the cardiac transcription factors Nkx2-5, HOPX, GATA4, and Mef2C, and upregulated structural proteins such as cardiac troponin T and alpha cardiac actin at both the protein and gene levels. In conclusion, our findings suggest that HDACi may serve as potential modulators of the energetic status and cardiomyogenic differentiation of human heart hmMSCs. This avenue of exploration could broaden the search for novel therapeutic interventions for dilated cardiomyopathy, ultimately leading to improvements in heart function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase InhibitorsMesenchymal Stem CellsCardiomyopathy, DilatedCell DifferentiationHumansMyocardiumHistone DeacetylasesMyocytes, CardiacMEF2 Transcription FactorsHomeobox Protein Nkx-2.5AcetylationTranscription FactorsCells, Cultured

Stichwörter der Autor:innen

dilated cardiomyopathyhistone deacetylate inhibitorsmesenchymal stem/stromal cells

Substanzen

Histone Deacetylase InhibitorsHistone DeacetylasesMEF2 Transcription FactorsHomeobox Protein Nkx-2.5Transcription Factors

Autor:innen und Institutionen

  • Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Santariškių 5, LT-08406 Vilnius, Lithuania.
  • Myomedix Ltd., Im Biengarten 36, 69151 Neckargemuend, Germany.

ORCID-Profile: Siegfried Labeit

Förderung

  • Lithuanian Research Council

Zitieren

APA

Mikšiūnas, R., Labeit, S., & Bironaite, D. (2024). Class I and II Histone Deacetylase Inhibitors as Therapeutic Modulators of Dilated Cardiac Tissue-Derived Mesenchymal Stem/Stromal Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126758

Vancouver

Mikšiūnas R, Labeit S, Bironaite D. Class I and II Histone Deacetylase Inhibitors as Therapeutic Modulators of Dilated Cardiac Tissue-Derived Mesenchymal Stem/Stromal Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126758

BibTeX
@article{Mikinas2024,
  author = {Mikšiūnas, Rokas and Labeit, Siegfried and Bironaite, Daiva},
  title = {Class I and II Histone Deacetylase Inhibitors as Therapeutic Modulators of Dilated Cardiac Tissue-Derived Mesenchymal Stem/Stromal Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25126758}
}
Kostenlos starten →